LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | PI103 | 3.33 | uM | LJP6 | 72 | hr | 962 | 1349 | 10605 | 0.1273 | 0.0402 |
MCF 10A | PLX-4720 | 3.33 | uM | LJP5 | 72 | hr | 962 | 9312 | 10605 | 0.8781 | 0.8659 |
MCF 10A | QL-X-138 | 3.33 | uM | LJP6 | 72 | hr | 962 | 2805 | 10605 | 0.2645 | 0.1911 |
MCF 10A | QL-XII-47 | 3.33 | uM | LJP6 | 72 | hr | 962 | 3256 | 10605 | 0.3071 | 0.2379 |
MCF 10A | Radicicol | 3.33 | uM | LJP5 | 72 | hr | 962 | 760 | 10605 | 0.0717 | -0.0209 |
MCF 10A | Radicicol | 3.33 | uM | LJP6 | 72 | hr | 962 | 758 | 10605 | 0.0715 | -0.0212 |
MCF 10A | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 962 | 8937 | 10605 | 0.8427 | 0.8270 |
MCF 10A | Ruxolitinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 9673 | 10605 | 0.9122 | 0.9034 |
MCF 10A | XL147 | 3.33 | uM | LJP5 | 72 | hr | 962 | 7621 | 10605 | 0.7186 | 0.6905 |
MCF 10A | Saracatinib | 3.33 | uM | LJP6 | 72 | hr | 962 | 5442 | 10605 | 0.5132 | 0.4646 |
MCF 10A | Selumetinib | 3.33 | uM | LJP6 | 72 | hr | 962 | 2226 | 10605 | 0.2099 | 0.1311 |
MCF 10A | Sirolimus | 3.33 | uM | LJP6 | 72 | hr | 962 | 9200 | 10605 | 0.8676 | 0.8544 |
MCF 10A | Sorafenib | 3.33 | uM | LJP6 | 72 | hr | 962 | 9121 | 10605 | 0.8601 | 0.8461 |
MCF 10A | SU11274 | 3.33 | uM | LJP5 | 72 | hr | 962 | 6858 | 10605 | 0.6467 | 0.6115 |
MCF 10A | Fedratinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 4226 | 10605 | 0.3985 | 0.3385 |
MCF 10A | TGX221 | 3.33 | uM | LJP5 | 72 | hr | 962 | 10595 | 10605 | 0.9991 | 0.9990 |
MCF 10A | Torin1 | 3.33 | uM | LJP6 | 72 | hr | 962 | 1594 | 10605 | 0.1503 | 0.0655 |
MCF 10A | Torin2 | 3.33 | uM | LJP5 | 72 | hr | 962 | 1380 | 10605 | 0.1302 | 0.0434 |
MCF 10A | Tozasertib | 3.33 | uM | LJP5 | 72 | hr | 962 | 1348 | 10605 | 0.1272 | 0.0401 |
MCF 10A | Trametinib | 3.33 | uM | LJP5 | 72 | hr | 962 | 1925 | 10605 | 0.1815 | 0.0998 |
MCF 10A | TWS119 | 3.33 | uM | LJP5 | 72 | hr | 962 | 9675 | 10605 | 0.9123 | 0.9036 |
MCF 10A | Vemurafenib | 3.33 | uM | LJP5 | 72 | hr | 962 | 8735 | 10605 | 0.8237 | 0.8061 |
MCF 10A | Withaferin A | 3.33 | uM | LJP5 | 72 | hr | 962 | 685 | 10605 | 0.0647 | -0.0287 |
MCF 10A | Withaferin A | 3.33 | uM | LJP6 | 72 | hr | 962 | 599 | 10605 | 0.0565 | -0.0376 |
MCF 10A | WYE-125132 | 3.33 | uM | LJP6 | 72 | hr | 962 | 1417 | 10605 | 0.1336 | 0.0472 |